2019 WHA Resolution on antimicrobial resistance

72nd WHA
28 May 2019

Analysis of precedential value

This Res­o­lu­tion was passed at 72nd World Health Assem­bly (WHA). The WHA is the deci­sion-mak­ing body of the World Health Orga­ni­za­tion (WHO). It includes del­e­ga­tions from every UN mem­ber state, which gather annu­ally to address ques­tions about WHO’s gov­er­nance, bud­get, and progress. Although WHA res­o­lu­tions are cen­tred on health, they engage var­i­ous related top­ics rang­ing from mil­i­tary aggres­sion to migrant rights.

Accord­ing to the WHO press team, “the res­o­lu­tion urges Mem­ber States to strengthen infec­tion pre­ven­tion and con­trol mea­sures includ­ing water san­i­ta­tion and hygiene; enhance par­tic­i­pa­tion in Global Antimi­cro­bial Sur­veil­lance Sys­tem; ensure pru­dent use of qual­ity-assured antimi­cro­bials; and sup­port mul­ti­sec­toral annual self-assess­ment sur­vey.”

Used as precedent

access to health products

Requests the Direc­tor Gen­eral to sup­port Mem­ber States to mobi­lize ade­quate pre­dictable and sus­tained fund­ing and human and finan­cial resources and invest­ment through national, bilat­eral and mul­ti­lat­eral chan­nels to sup­port the devel­op­ment and imple­men­ta­tion of national action plans, research and devel­op­ment on exist­ing and new antimi­cro­bial med­i­cines, diag­nos­tics, and vac­cines, and other tech­nolo­gies, and strength­en­ing of related infra­struc­ture, includ­ing through engage­ment with mul­ti­lat­eral devel­op­ment banks and tra­di­tional and vol­un­tary inno­v­a­tive financ­ing and invest­ment mech­a­nisms, based on pri­or­i­ties and local needs set by gov­ern­ments and on ensur­ing pub­lic return on invest­ment.